Peter Young

Peter Young is a Senior Venture Partner at Pappas Capital with an extensive background in the life sciences industry.12 He joined Pappas Capital in 2012, initially serving as an Executive-in-Residence before transitioning to his current role.2

Professional Experience

Peter Young has 40 years of experience in the pharmaceutical and biotechnology industries.12 His career spans various roles, including:

• Sales representative
• Country-level general manager
• CEO
• Vice President and Therapy Area Head at Glaxo Wellcome

During his time at Glaxo Wellcome in the mid-1990s, Young led the global introduction of combination HIV therapy, which revolutionized HIV treatment and significantly increased Glaxo's global HIV portfolio sales.2

Current Responsibilities

At Pappas Capital, Peter Young:

• Leads the firm's initiatives in translational medicine12
• Serves as the Program Manager for the Wake Forest Technology Development Program2
• Provides business development and due diligence support to the firm's venture funds and portfolio companies2

Board Positions and Affiliations

Peter Young currently holds several positions:

• Director for Veralox Therapeutics
• Observer for Sorriso Pharmaceuticals and Ribometrix
• Member of the Oversight Committee for the University of Miami Wallace H. Coulter Center for Translational Research
• Advisory board member for New York State's Empire Discovery Institute
• Executive-in-Residence at Cold Spring Harbor Laboratory and Stony Brook University Center for Biotechnology
• Mentor-in-Residence at Rutgers University

Education

Peter Young holds the following degrees:

• BA in History from Indiana University
• MBA from Indiana University Kelley School of Business2

His LinkedIn profile can be found under the username peter-young-ba10396.3